Epigenetics and immunotherapy: The current state of play-Reference-Cited by-同舟云学术

Epigenetics and immunotherapy: The current state of play

Published:2017-07 Issue: Volume:87 Page:227-239
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Dunn Jennifer,Rao Sudha

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference138 articles.

1. BET bromodomain inhibition synergizes with immune checkpoint blockade to facilitate anti-tumor response in a murine model of non-small cell lung cancer harboring KRAS mutation;Adeegbe;J. Immunol.,2016

2. Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment;Ahearne;Br. J. Haematol.,2014

3. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma;Ansell;N. Engl. J. Med.,2015

4. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate;Armeanu;Cancer Res.,2005

5. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers;Badoual;Clin. Cancer Res.,2006

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unleashing precision: A review of targeted approaches in pleural mesothelioma;Critical Reviews in Oncology/Hematology;2024-11

2. Loss of histone deubiquitinase Bap1 triggers anti-tumor immunity;Cellular Oncology;2024-08-14

3. The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets;Clinical and Translational Medicine;2024-08

4. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer;Molecular Cancer;2024-05-07

5. Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream;Frontiers in Immunology;2024-01-08